Solvay, a pioneering company in science and materials, is partnering with Ginkgo Bioworks to unlock the potential of synthetic biology and create more sustainable chemicals and materials. This multi-year strategic collaboration will focus on creating biopolymers, specialties that could revolutionize markets from home and personal care to food and agriculture. Together, Solvay and Ginkgo Bioworks are leading the way towards a more environmentally-friendly future.
Solvay is delighted to announce a new partnership with Ginkgo (formerly Zymergen) that will see Solvay acquire a laboratory in Cambridge, Massachusetts. This move will bolster Solvay’s research and innovation capabilities in the United States and give them access to a wealth of new talent. It is also a key milestone in the company’s ambition to become a leader in synthetic biology, allowing them to capitalise on one of the most vibrant biotech hubs in the world.
Solvay is taking a major leap forward in its biotechnology capabilities by entering into a strategic collaboration and expansion. Through this venture, the company will be able to gain valuable insights into the rapidly-evolving world of bioinformatics, data science, strain engineering, biocatalysis, and fermentation processes.
With these new capabilities, Solvay can scout, develop, and turn into businesses the most promising and profitable biotech-enabled opportunities – faster than ever before.
Solvay is proud to announce an exciting new partnership to strengthen its position in biotechnology – a key part of the company’s Renewable Materials and Biotechnology growth platform.
This platform is designed to meet the growing demand for sustainable solutions by increasing the share of renewable carbon in Solvay’s product offering and leveraging the potential of biotechnology to create new business opportunities.
With this, Solvay is expanding its activities in the fields of battery materials, green hydrogen and thermoplastic composites, setting the stage for a bright future.
Solvay is thrilled to be taking a major step forward in the biotech industry with its new partnership with Ginkgo Bioworks. This exciting project will develop sustainable chemicals and materials, enabling the company to provide innovative biotechnologies to new markets.
With its new presence in the Boston area, Solvay is looking to grow and accelerate its offerings in this field, positioning itself as an industry leader in this rapidly evolving field.
We are thrilled to welcome Solvay to Boston and to our platform at such an important time of growth for both our companies! As part of this partnership, we are excited to make our platform capabilities from Zymergen accessible to our partners.
Our goal is to use synthetic biology to help companies across a variety of markets reach their environmental and economic goals. It’s an incredible opportunity to work with a partner that is taking such a bold stance on sustainability.
About Solvay
With its innovative solutions, Solvay is making the world a better place. Employing over 22,000 people in 61 countries, this science company is committed to creating sustainable shared value through its Solvay One Planet roadmap. This roadmap focuses on three pillars: protecting the climate, preserving resources and fostering a better life.
Thanks to Solvay, everyday products and devices such as homes, food, planes, cars, batteries, smart devices, health care applications, water and air purification systems are becoming safer, cleaner and more sustainable. Founded in 1863, Solvay is now one of the top three companies in the world and delivered net sales of €13.4 billion in 2022. Solvay is listed on Euronext Brussels and Paris (SOLB).
About Solvay’s Renewable Materials and Biotechnology platform
Solvay is committed to creating innovative and sustainable solutions using renewable feedstocks and biotechnology that meet the growing demand for sustainability. To achieve this ambition, the company has established its Renewable Materials and Biotechnology Growth Platform, which focuses on three interconnected pillars: sustainable renewable carbon, biotechnology and end-of-life management.
Through this platform, Solvay is leveraging its expertise to develop new business opportunities and increase the share of sustainable renewable carbon in its product offering. This investment is a key part of the company’s strategy to build a future based on renewable materials and biotechnology.
About Ginkgo Bioworks
Ginkgo Bioworks is revolutionizing the way we engineer cells, transforming a wide range of industries, from food and agriculture to pharmaceuticals and industrial chemicals. But they don’t stop there.
Their Concentric by Ginkgo unit is creating a world-wide infrastructure for biosecurity, so governments, communities, and public health officials can protect us all from the dangers of biological threats. It’s an incredible mission, and one that’s changing the world for the better.